Daily Analyst Ratings
Real-time FMP upgrades, downgrades, initiations and reiterated coverage.
Limited daily previewLast updated 5 hrs ago
Analyst Intelligence3 sample rows visible. INVESTOR unlocks all data.
View pricing0Upgrades Today0 in loaded feed
0Downgrades Today0 in loaded feed
0Initiated Coverage0 in loaded feed
0Target Raises4 in loaded feed
0Target Cuts4 in loaded feed
All Rating & Target Events
10/11/2026 – 14/11/2026 · Israel time · Updated daily
8 complete analyst events
Target RaisedBuy→Buy
Price$18.96
Target$22Prior target not reported
Upside+16.0%
OCOliver Chen · Cowen & Co.
Source: Sally Beauty Holdings (SBH) PT Raised to $22 at TD CowenTarget CutBuy→Buy
Price$111.60
Target$137Prior target not reported
Upside+22.8%
C&Analyst not provided · Cowen & Co.
Source: Twist Bioscience (TWST) PT Lowered to $137 at TD CowenTarget RaisedBuy→Buy
Price$275.39
Target$352Prior target not reported
Upside+27.8%
C&Analyst not provided · Cowen & Co.
Source: Ascendis Pharma (ASND) PT Raised to $352 at TD CowenTarget RaisedOutperform→Outperform
Price$10.32
Target$14Prior target not reported
Upside+35.7%
MSMatthew Swanson · RBC Capital
Source: Nexxen (NEXN) PT Raised to $14 at RBC CapitalTarget CutOutperform→Outperform
Price$9.43
Target$11Prior target not reported
Upside+16.6%
AVArun Viswanathan · RBC Capital
Source: Corteva Inc. (CTVA) PT Lowered to $11 at RBC CapitalTarget CutOutperform→Outperform
Price$40.97
Target$59Prior target not reported
Upside+44.0%
BDBart Dziarski · RBC Capital
Source: Brookfield Corporation (BN) PT Lowered to $59 at RBC CapitalTarget CutOutperform→Outperform
Price$89.35
Target$106Prior target not reported
Upside+18.6%
BAnalyst not provided · Bernstein
Source: CVS Health (CVS) PT Lowered to $106 at Bernstein SocGen GroupTarget RaisedBuy→Buy
Price$24.89
Target$33Prior target not reported
Upside+32.6%
MSMauricio Serna · UBS
Source: Wolverine World Wide (WWW) PT Raised to $33 at UBS Amid Industry-Wide Promotional Pressures| Action | Rating Change | ||||||
|---|---|---|---|---|---|---|---|
| 13 / 11 / 2026Source | OCOliver ChenCowen & Co. |  SBH | Target Raised | Buy Maintained | $22Prior target not reported | $18.96 | +16.0% |
| 13 / 11 / 2026Source | C&Cowen & Co.Research firm |  TWST | Target Cut | Buy Maintained | $137Prior target not reported | $111.60 | +22.8% |
| 13 / 11 / 2026Source | C&Cowen & Co.Research firm |  ASND | Target Raised | Buy Maintained | $352Prior target not reported | $275.39 | +27.8% |
| 13 / 11 / 2026Source | MSMatthew SwansonRBC Capital |  NEXN | Target Raised | Outperform Maintained | $14Prior target not reported | $10.32 | +35.7% |
| 13 / 11 / 2026Source | AVArun ViswanathanRBC Capital |  CTVA | Target Cut | Outperform Maintained | $11Prior target not reported | $9.43 | +16.6% |
| 13 / 11 / 2026Source | BDBart DziarskiRBC Capital |  BN | Target Cut | Outperform Maintained | $59Prior target not reported | $40.97 | +44.0% |
| 13 / 11 / 2026Source | BBernsteinResearch firm |  CVS | Target Cut | Outperform Maintained | $106Prior target not reported | $89.35 | +18.6% |
| 13 / 11 / 2026Source | MSMauricio SernaUBS |  WWW | Target Raised | Buy Maintained | $33Prior target not reported | $24.89 | +32.6% |